Literature DB >> 3397805

Nonoliguric hyperkalemia in the premature infant weighing less than 1000 grams.

J Gruskay1, A T Costarino, R A Polin, S Baumgart.   

Abstract

Eighteen very low birth weight premature infants born before 28 weeks gestation and weighing less than 1000 gm were evaluated prospectively for disturbances in serum electrolyte concentrations and for renal glomerular and tubular functions. Clinically symptomatic hyperkalemia resulting in significant electrocardiographic dysrhythmias developed in eight of these infants; 10 babies remained normokalemic. Peak serum potassium concentration ranged from 6.9 to 9.2 mEq/L in the hyperkalemic group; all potassium values in the normokalemic group were less than 6.6 mEq/L. Indices of renal glomerular function and urine output were similar in both groups; no infant had oliguria. Serum creatinine concentrations were the same in both groups (1.04 +/- 0.16 SD mg/dl in normokalemic vs 1.19 +/- 0.24 mg/dl in hyperkalemic infants, beta less than 0.2 at alpha = 0.05), and glomerular filtration rates did not differ significantly (6.29 +/- 1.78 ml/min/1.73 m2 in normokalemic vs 5.70 +/- 1.94 ml/min/1.73 m2 in hyperkalemic infants, beta less than 0.2 at alpha = 0.05). In contrast, indicators of tubular function revealed a significantly larger fractional excretion of sodium in hyperkalemic infants: 13.9 +/- 5.4% versus 5.6 +/- 0.9% in normokalemic control subjects (p less than 0.001). Hyperkalemic infants also had a tendency toward lower urine concentrations of potassium, although there was no significant difference in their net potassium excretion in comparison with that in the normokalemic group. We speculate that hyperkalemia in the tiny baby is in part the result of immature distal tubule function with a compromise in ability to regulate potassium balance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397805     DOI: 10.1016/s0022-3476(88)80288-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

Review 1.  Interventions for non-oliguric hyperkalaemia in preterm neonates.

Authors:  Prakash Vemgal; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Proceedings of the American Society of Pediatric Nephrology Educational Symposium, San Diego, California, 7 May 1995.

Authors: 
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Erythrocyte sodium-potassium transport in hyperkalaemic and normokalaemic infants.

Authors:  Y Matsuo; K Hasegawa; Y Doi; A Kinugasa; M Uchiyama; T Sawada
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

Review 4.  Potassium transport in the maturing kidney.

Authors:  Sevgi Gurkan; Genevieve K Estilo; Yuan Wei; Lisa M Satlin
Journal:  Pediatr Nephrol       Date:  2007-03-02       Impact factor: 3.714

5.  Guidelines for transfusion of erythrocytes to neonates and premature infants. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-12-15       Impact factor: 8.262

6.  Early hyperkalaemia in very low birthweight infants in the absence of oliguria.

Authors:  L P Brion; G J Schwartz; D Campbell; A R Fleischman
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

7.  Sodium and potassium clearances by the maturing kidney: clinical-molecular correlates.

Authors:  Mercedes M Delgado; Rajeev Rohatgi; Shahana Khan; Ian R Holzman; Lisa M Satlin
Journal:  Pediatr Nephrol       Date:  2003-06-17       Impact factor: 3.714

8.  Renal function in sick very low birthweight infants: 3. Sodium, potassium, and water excretion.

Authors:  B H Wilkins
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

9.  Nonoliguric hyperkalemia in a late preterm infant with severe birth asphyxia.

Authors:  Xiaoyu Xiong; Dan Chen; Jing Zhang; Jian Mao; Juan Li
Journal:  Transl Pediatr       Date:  2013-01

Review 10.  Potassium homeostasis and its disturbances in children.

Authors:  J Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.